08:00 , Nov 16, 2009 |  BioCentury  |  Finance

Ebb & Flow

Although the terms of the acquisition of BioTrove Inc. by Life Technologies Corp. (NASDAQ:LIFE) haven't been undisclosed, the transaction could result in a more than 10X return over the next 12 months, according to investor...
07:00 , Apr 7, 2008 |  BioCentury  |  Finance

Ebb & Flow

For small companies with constrained options in the current financing environment, alternative approaches tied to royalty or revenue interests continue to be the order of the day. Last week, a trio of alternative vehicles went...
08:00 , Jan 2, 2006 |  BioCentury  |  Finance

Profiling Perlegen's money

Profiling Perlegen's money Profiling Perlegen's money Perlegen has raised $207 million in private financings, but less than 15% has come from traditional VCs. The private rounds exclude the $50 million that Pfizer (PFE) invested last...
03:44 , Mar 1, 2005 |  BC Extra  |  Financial News

Perlegen raises $74M

Pharmacogenomics company Perlegen (Mountain View, Calif.) raised $74 million in a series D round led by CSK Venture. New investors Brookside Capital; Mizuho Securities; Glynn Capital; and Cape Securities joined existing investors Alex Zaffaroni; Maverick;...
07:00 , May 17, 2004 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe Company Country Raised (M) Investors Speedel Switzerland $57.6 Novartis; DSM Venturing Intercell Austria $50.0 Global Life Science Ventures; Apax Partners; Nomura International; TVM Techno Venture Management; NIB; Star Ventures; MPM Capital...
07:00 , Apr 5, 2004 |  BioCentury  |  Finance

Ebb & Flow

Private investors continued their love affair with the life sciences, as Alta Partners raised $475 million for two funds last week, and - in a slight change of direction - all of the money will...
08:00 , Mar 31, 2004 |  BC Extra  |  Financial News

Salmedix raises $45M

Cancer company Salmedix raised $45 million in a series C round led by HIG Ventures. Other investors included OrbiMed; Easton Hunt; Hunt Ventures; Novo A/S; Quilvest Capital; Clariden Bank; InterWest; Versant; Alexandria Equities; CMEA; Delphi;...
08:00 , Jan 29, 2004 |  BC Extra  |  Financial News

BioTrove raises $10.9 million

Assay company BioTrove (Woburn, Mass.) raised $10.9 million in series B round. Investors included Catalyst Health and Technology Partners; CB Health Ventures; Zero Stage Capital; and BioFrontier Partners. Ben Bronstein, a managing director at ZeroStage,...
08:00 , Mar 24, 2003 |  BioCentury  |  Finance

Ebb & Flow

Echoing a trend seen on the company side, banks both big and small continue to search for the headcount sweetspot in the midst of the bear market. Last week's choppers included merchant banker Thomas Weisel...
08:00 , Mar 18, 2003 |  BC Extra  |  Financial News

Cellzome raises EUR 30 million

In the largest biotech venture capital round in Europe this year, Cellzome (Heidelberg, Germany) raised EUR 30 million ($32.2 million) in a series C round led by Invesco Private Capital. Other investors included Biofrontier Partners;...